Incisive Genetics: Raises $2.5M in Seed Funding

Incisive Genetics Raises $2.5M in Seed Funding

  • Incisive Genetics, a Vancouver BC-based held biotech company, raised $2.5M in seed funding
  • The round was led by investors Noel Hall and Sandra MacPherson of the MacHall group and Haig Farris, OC
  • The company intends to use the funds to develop its manufacturing process and capabilities, advance key studies to enhance its gene editing delivery platform technology
  • Established in 2018 and led by Dr. Blair R. Leavitt, IncisiveGenetics provides a non-viral delivery platform for genetic therapies
  • This delivery platform enables a one-step encapsulation of the active CRISPR components within lipid nanoparticles
  • The company’s pre-clinical pipeline includes programs addressing neurologic and ocular genetic diseases
Steve Sam
Steve Sam
Steve Sam is a financial reporter, analyst, and commentator with a strong focus on banking technology, digital payments, and the future of financial services.

You May Also Like

Kulipa Secures $62M to Enhance Stablecoin Card Issuing Infrastructure

Funding aims to strengthen cryptocurrency card services in the growing fintech market. Highlights: Kulipa raises $62M to enhance its...

Visa Launches AI-Powered Dispute Resolution Tools

New tools aim to streamline resolution of payment disputes. Highlights: Visa introduces AI tools for payment dispute resolution.The new...

UK Fintechs Vibepay and SmartLayer Shut Down

Both companies cease operations amidst challenging market conditions. Highlights: Vibepay and SmartLayer have officially ceased operations.The closures are attributed...

Visa and Ramp Boost Bill Pay Automation with Agentic AI

New integration aims to streamline corporate expense management processes. Highlights: Visa and Ramp announce partnership to automate corporate bill...